NUTX | Ticker Profile - Titan Protect

NUTX

Nutex Health Inc.

Healthcare · Medical Care Facilities · NCM

$132.59

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$822M

Total market value of the company

Trailing P/E

8.97

Very cheap relative to earnings

Forward P/E

5.88

Based on estimated future earnings — lower means cheaper

Rev Growth

+2.2%

Year-over-year revenue change

Profit Margin

11.0%

How much profit the company keeps from each dollar of revenue

ROE

53.6%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$232.00

+75% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 3 analysts covering this stock

About Nutex Health Inc.

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

https://www.nutexhealth.com

Country: United States Employees: 1,005 Industry: Medical Care Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

1.853

Excellent risk-adjusted returns

Kelly Fraction

0.1469

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

6.237

Returns exceed worst-case losses — strong risk profile

Annual Return

338.9%

Historical annualised return based on price data

Max Drawdown

-54.3%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

2.07

Significantly more volatile than the market

52W High

$193.07

31% below the year high

52W Low

$77.21

72% above the year low

Avg Volume

191,024

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.8

Days it would take all short sellers to cover — higher means more crowded

Short % Float

21.0%

Very high short interest — potential squeeze candidate

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$13.32

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

78.97

Heavy leverage — higher financial risk if revenues decline

Current Ratio

3.14

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

3.00

Like current ratio but excludes inventory — stricter test

Gross Margin

50.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

37.5%

Profit from core operations before interest and tax

Free Cash Flow

$169M

Positive — the business generates more cash than it spends

Revenue (TTM)

$880M

Total revenue over the last 12 months

Net Income

$96M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$300.00

Target Median

$232.00

Target Low

$175.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go